(Q36090194)

12 August 2017

1 reference

title

Targeting the innate immune response with improved vaccine adjuvants (English)

1 reference

12 August 2017

1 reference

Achal Pashine

1

1 reference

12 August 2017

Nicholas M Valiante

series ordinal

2

1 reference

12 August 2017

Jeffrey B Ulmer

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

11

1 reference

12 August 2017

issue

4 Suppl

1 reference

12 August 2017

page(s)

S63-8

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1210

12 August 2017

exact match

0 references

cites work

The interface between innate and adaptive immunity

1 reference

Innate immunity: the virtues of a nonclonal system of recognition

21 January 2018

1 reference

Approaching the asymptote? Evolution and revolution in immunology

21 January 2018

1 reference

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

Pattern recognition receptors: doubling up for the innate immune response

21 January 2018

1 reference

Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A.

21 January 2018

1 reference

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

21 January 2018

1 reference

Toll-like receptor signalling

21 January 2018

1 reference

Role of adapters in Toll-like receptor signalling

21 January 2018

1 reference

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

21 January 2018

1 reference

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

21 January 2018

1 reference

Immunobiology of dendritic cells

21 January 2018

1 reference

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

Modulating vaccine responses with dendritic cells and Toll-like receptors

21 January 2018

1 reference

Toll-like receptors and T-helper-1/T-helper-2 responses

21 January 2018

1 reference

Toll-dependent control mechanisms of CD4 T cell activation.

21 January 2018

1 reference

Adjuvants for human vaccines--current status, problems and future prospects

21 January 2018

1 reference

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum

21 January 2018

1 reference

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

Recent advances in the discovery and delivery of vaccine adjuvants

21 January 2018

1 reference

Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells.

21 January 2018

1 reference

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

21 January 2018

1 reference

Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides

21 January 2018

1 reference

A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells

21 January 2018

1 reference

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

21 January 2018

1 reference

7 January 2021

Research and development of new vaccines against infectious diseases

1 reference

7 January 2021

Generation and maintenance of immunological memory

1 reference

7 January 2021

Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide

1 reference

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

7 January 2021

Cationic microparticles are a potent delivery system for a HCV DNA vaccine

1 reference

7 January 2021

Aluminium adjuvants--in retrospect and prospect

1 reference

7 January 2021

Aluminium compounds for use in vaccines

1 reference

7 January 2021

Technological advances in high-throughput screening

1 reference

7 January 2021

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

7 January 2021

PI3K and negative regulation of TLR signaling.

1 reference

7 January 2021

Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2.

1 reference

7 January 2021

Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors

1 reference

7 January 2021

Antiviral and antitumor peptides from insects.

1 reference

7 January 2021

IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo

1 reference

7 January 2021

Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines

1 reference

7 January 2021

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

1 reference

7 January 2021

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

1 reference

7 January 2021

Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling

1 reference

7 January 2021

4th meeting on Novel Adjuvants Currently in/close to Human Clinical Testing World Health Organization -- organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23-25, June 2003

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1210

1 reference

Dimensions Publication ID

12 August 2017

1019008331

0 references

Fatcat ID

release_ywfsuckqtneqzjdzrvtzzsurfq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ywfsuckqtneqzjdzrvtzzsurfq

24 November 2022

mapped directly with Wikidata item

1 reference